Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The onset of the therapeutic response to antidepressant treatment exhibits a characteristic delay. Animal models sensitive to chronic, but not acute, antidepressant treatment are greatly needed for studying antidepressant mechanisms. We initially assessed four inbred mouse strains for their behavioral response to chronic treatment with the selective-serotonin reuptake inhibitor fluoxetine (0, 5, 10 mg/kg/day in drinking water), which is used for the treatment of mood and anxiety disorders. Only the highly anxious BALB/c strain exhibited sensitivity to fluoxetine in the forced swim test. Additionally, fluoxetine reduced locomotion in C57BL/6 and 129SvEv, but not BALB/c and DBA/2, strains. We then evaluated the effects of subchronic (approximately 4 days) and chronic (approximately 24 days) fluoxetine treatment (0, 10, 18, 25 mg/kg/day) on measures of anxiety and depression in BALB/c mice. Anxiety measures were obtained using the open field and novelty-induced hypophagia tests. Antidepressant effects were evaluated using the forced swim test. We found 18 mg/kg/day of chronic fluoxetine to be active in all three paradigms; subchronic treatment had no effect. Anxiety-related measures were reduced by 18 mg/kg/day. In the forced swim test, 10 and 18 mg/kg/day increased swimming and reduced immobility. Here we present several novel effects of chronic, but not subchronic, antidepressant treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This dosage of 18 mg/kg/day have been shown to be in the upper range of the therapeutic dose of fluoxetine administered to humans.16”
From Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression (2025) · cites this paper as [16]
In the citing paper
“Hyponeophagia (novelty-suppressed feeding) has also been used to assess anxiety-like behavior in rodents; in a novel environment, hungry mice exhibit an increased latency to feed that is sensitive to benzodiazepines and SSRIs47,48.”
From Resolving the neural circuits of anxiety (2015) · cites this paper as [47]
In the citing paper
“The NIH paradigm is a sensitive measure for potential anxiolytic drugs and anxiogenic effects of withdrawal on both acute and extended drug administration paradigms (Dulawa et al., 2004;Dulawa and Hen, 2005).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Dulawa et al., 2004
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“We have previously shown that steady state for both fluoxetine and norfluoxetine is achieved by 5 days of receiving fluoxetine in the drinking water (10 mgskgsday), as serum levels after 5 or 90 days of treatment are equivalent (”
BackgroundSelf-citationBehavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,013
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,175
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“The intake of palatable fluids, including sucrose and saccharin solutions, has been used as a measure of reward sensitivity (”
MethodAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Antidepressants and neuroplasticity
D'Sa, C., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 513 · cited 1×
“These long-term effects are thought to involve increases in neural plasticity and growth-related events (”
Background
Research works printed but not linked: 2
- Hirschfeld R, Weisssman M (2002). Risk factors for major depression and bipolar disorder. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 1018–1025.
- Merikangas K, Pine D (2002). Genetic and other vulnerability factors for anxiety and stress disorders. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 868–882.
Cited by
Items 601–693 of 693
김기정, 김보균, Kim, Y.-P., 성윤희, Kim, C., Jin, H.-J., Seo, J., & 김대영 (2009) · Exercise Science · doi:10.15857/ksep.2009.18.3.401
Antidepressant Action and Hippocampal Neuronal Plasticity
Kobayashi, K. (2014) · Nihon Ika Daigaku Igakkai Zasshi · doi:10.1272/manms.10.6
Obsessive–compulsive disorder and Gilles de la Tourette syndrome
Woehrle, N. S., & Dulawa, S. C. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.016
Self-citationGershenfeld, H. K. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139541022.020 · Cited by 1
Endocannabinoid Modulation of Post-Ischemia Depression
Bonneville, M. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5185
“shown to reduce immobility on the FST in rodents with a depressive-like phenotype (Dulawa, 2004).”
BackgroundImmaturity of brain as an endophenotype of neuropsychiatric disorders
Hagihara, H., Shoji, H., & Miyakawa, T. (2016) · Folia Pharmacologica Japonica · doi:10.1254/fpj.148.168
Lee, H., Rao, J. S., Ertley, R. N., Chang, L., Rapoport, S. I., & Bazinet, R. P. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4499-z
Rao, N., Basavrajeswari, B., Ravishankar, B., Shrikanth, U., & Chaturvedi, A. (2017) · International Journal of Research in Ayurveda and Pharmacy · doi:10.7897/2277-4343.0819
Psychopharmacological Profile of Ascorbate in aged Wistar Rats
RostirolaElsner, V., Moysés, F. D. S., Bertoldi, K., & Siqueira, I. R. (2017) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000153
“Although the selective serotonin reuptake inhibitors have been reported to be effective treatments for generalized anxiety disorder, previous studies have demonstrated that acute treatment with antidepressants induces anxiogenic-like effects [30,31].”
ResultReznikov, R. (2015) · TSpace (University of Toronto)
Harmony, Z. R. (2014) · CSUSB ScholarWorks (California State University, San Bernardino)
Melo, W. (2014) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2014.11.d.17573 · Cited by 2
Cortical Astroglial Plasticity in Response to Stress and Antidepressant Treatment
Simard, S. (2017) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2017-11815
青光眼小鼠Thy1-CFP-DBA/2J表达melanopsin蛋白的视网膜节细胞的丢失及小鼠行为学分析
王, 艳., Brecha, N. C., 高, 洁., 黄, 鑫., Vuong, H. E., 张, 琦., & 濮, 鸣. (2013) · Scientia Sinica Vitae · doi:10.1360/zc2013-43-8-631
Adolescent anabolic steroid exposure alters anxiety through aggression circuits
Morrison, T. R. (2016) · Digital Repository Service (Northeastern University) · doi:10.17760/d20213405
Efeitos comportamentais e neuroplásticos da combinação de escitalopram e canabinóides
Scarante, F. F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-25072018-103829 · Cited by 2
Antidepressant-like effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Majumder, I. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Avaliação do risco ambiental da fluoxetina em sedimentos marinhos para invertebrados aquáticos
dos Santos, D. R. A. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.85.2019.tde-11042019-144512 · Cited by 5
Shail, P. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13423
Mozhui, K. (2009) · doi:10.21007/etd.cghs.2009.0219
“A decrease in immobility is similar to that seen with antidepressant treatment (Cryan & Holmes, 2005) and was therefore an unexpected consequence of restraint, especially in this characteristically high-anxiety and stress-reactive strain (Anisman et al., 2001; Belzung & Griebel, 2001; Dulawa et al., 2004; Norcross et…”
MethodFaye, C. (2019) · theses.fr (ABES) · doi:10.70675/b3ef3280z5adbz4bf3za491zddb2cbdf6aa0 · Cited by 1
Pharmacotherapy of diet-restriction-induced-anorexia nervosa with fluoxetine in rats
Saleem, D. M., Jabeen, Z., & Haleem, D. J. (2019) · AIP conference proceedings · doi:10.1063/1.5123701
EFFECT OF FLUOXETINE ON THE STRUCTURE OF ALVEOLAR BONE IN RATS WITH DEPRESSION
Mohamed, A. S., Kawana, K., & Karam, S. S. (2019) · Alexandria Dental Journal · doi:10.21608/adjalexu.2019.63563
The effects of perinatal Fluoxetine treatment on offspring behaviour and neurobiology
Millard, S. J. (2019) · Research Online (University of Wollongong)
Ramirez, F., & Javier, F. (2020) · scholarworks - UTEP (The University of Texas at El Paso)
Carratalá‐Ros, C. (2020) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14109.2020.368729
5-HT2B Receptors and Antidepressants
Diaz, S. L. (2021) · The Receptors · doi:10.1007/978-3-030-55920-5_21
Effects of antidepressants on the ventral dentate gyrus
Arias, E. C. (2021) · Columbia Academic Commons (Columbia University) · doi:10.7916/d8-4gaa-1e71
Sheikh, S., Pankaj, S., Veena, V., Tripathi, C. D., Ahmed, K. B., & Meshram, G. G. (2021) · Open Journal of Pharmacology and Pharmacotherapeutics · doi:10.17352/ojpp.000016
“Interestingly, when citalopram and fl uoxetine are administered chronically they cause signifi cant reduction in the immobility time [25-27], probably explaining the therapeutic lag seen in SSRIs.”
BackgroundDoan, J. (2020) · theses.fr (ABES) · doi:10.70675/4cac5eccz728az41a4z8461z85b9e8ddfa1e · Cited by 1
Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_31-1
Analysis of possible antidepressant effects of Cordia Myxa extract in male rats: Behavioral study
Habeeb, Y. J., Selman, S. M., & Mahrath, A. J. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.6512
“wooden box (100 x 100cm) was built by a researcher and consists of a square floor divided into 100 equal squares by thin white lines[10].”
MethodStressor and cytokine interactions : implications in depressive-like pathology
Gibb, J. (2011) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2011-09658
Suljević, D., Mitrašinović‐Brulić, M., Škrijelj, R., & Fočak, M. (2023) · Comparative Clinical Pathology · doi:10.1007/s00580-023-03435-8
Lévy statistics define anxiety and depression in mice subjected to chronic stress
Li, Q., Li, X., Zhong, Q., Nie, Y., Luo, Y., Zhao, B., Zhang, N., Kuang, W., Tian, C., 陈道君, et al. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1757347
Scarante, F. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-29062023-112405
Verma, V., Sanone, P. P., Mehta, A. K., & Tripathi, C. D. (2023) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20232573
Fricke, H. P., Krajco, C. J., Perry, M. J., Brettingen, L. J., Wake, L. A., Charles, J. F., & Hernandez, L. L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1244580
Ghai, U., Chachra, P., Fanibunda, S. E., Mendon, S., Bhaskaran, A., Sarkar, A., Kukkemane, K., Singh, V. K., & Vaidya, V. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.29.573529
“…during early life collectively suggests differential effects on the programming of adult anxio-depressive behaviors, with reports of enhanced, decreased or no change in anxio-depressive behaviors, based on both the temporal window of administration and methodological differences (7–10 , 18–24).”
BackgroundLucich, A. C., Campos-Salazar, A. B., Matsuda, V. D. V., Cueva, K. Y., Carrillo, J. S., & Mercado, G. O. (2024) · Revista Colombiana de Ciencias Químico Farmacéuticas · doi:10.15446/rcciquifa.v52n3.111080
“RP mice was treated with pregabalin (Lyrica™; Pfizer, Madrid, Spain) with a single oral dose of 30 mg/kg [14], while the RF mice received fluoxetine (Prozac™, Eli Lilly Interamerica, Indianapolis, USA) in a single oral dose of 10 mg/kg [21, 22].”
MethodRepositioning Fluoxetine as a TRPV3 Channel Inhibitor to Alleviate Skin Inflammation and Pruritus
Zhang, L., Chang, J., Xu, Y., Ge, Q., & Zhang, C. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040277
“An animal study on fluoxetine’s antidepressant effect showed that at an oral dose of 10 mg/kg administered daily, it took at least 24 days to work [37].”
Riga, V. D., Makhortykh, A. E., Galstyan, D. S., de Abreu, M. S., & Kalueff, A. V. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115677
van den Buuse, M., Wilson, K.-E., Payet, J. M., & Hale, M. W. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.09.032
Kim, J. H., Kim, S.-S., Lee, E. H., Oh, S.-J., Hong, G.-S., Lee, B., Cho, I., Choi, C. W., Kang, T., & Kim, M. S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178363
The influence of cyclin D2 gene knockout on the hippocampus-dependent behavior in mice
Jedynak, P. (2014) · Figshare · doi:10.6084/m9.figshare.1120616
Fakheri, S. T., Changizi, R., Manouchehri, H., Emran, A. T. N., Ahangarkolaei, M. N., Saeedi, M., & Siahposht-Khachaki, A. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70092
Wood, B. J., Vest, M. F., Carfagno, C., Bartley, K. R., Sharma, P., Halberstadt, A. L., Blough, B. E., & Murnane, K. S. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00484
Trupiano, M. X., McCarthy, D. M., & Bhide, P. G. (2026) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2026.03.006
Analyse de profils d'expression génique dans des modèles murins d'anxiété/dépression
Xia, L. (2012) · theses.fr (ABES) · doi:10.70675/287ae503z3613z4b68z8a4fz308199883026
Orvoën, S. (2012) · theses.fr (ABES) · doi:10.70675/fc4072b8z23c7z4c2bzb5adz05babcfc2144
Lutz, P.-É. (2012) · theses.fr (ABES) · doi:10.70675/bc5e36d2z7056z4f14zbe49zb6e914ded93d
Nguyen, T. H. (2011) · theses.fr (ABES) · doi:10.70675/95d75bd8zdd5bz4677zaf98zc9268bd885f9 · Cited by 2
“Similarly, SSRIs are effective in animal models of high anxious-like states, but not in controls or in non-anxious strains ofmice (David et al., 2009; Dulawa et al., 2004).”
BackgroundCaffin, F. (2012) · theses.fr (ABES) · doi:10.70675/b13daadcz957cz4028z9892z0d5f5c7e864b · Cited by 1
“De ce fait, en général, les animaux présentent un haut degré d’évitement de l’aire centrale par rapport à la périphérie (Dulawa et al., 2004), à contrario d’animaux sous anxiolytiques, qui vont aller plus souvent et passer plus de temps dans l’aire centrale (Prut & Belzung, 2003).”
BackgroundStil, A. (2011) · theses.fr (ABES) · doi:10.70675/0a615ab8z65c9z451az9b08zc423d6cb7d77 · Cited by 1
Mood disruption in heroin abstinence : mechanisms and gene discovery
Ayrancı, G. (2015) · theses.fr (ABES) · doi:10.70675/a956874cz8192z4eb4zb9dez3ceb46a28053
Role of the orphan receptor GPR88 in psychiatric and motor disorders
Meirsman, A. C. (2015) · theses.fr (ABES) · doi:10.70675/a47243a0z75fbz4351zb63az4a17beff185e
ANIMAL Antidépresseurs, neuroinflammation et maladie d'alzheimer
Gosselin, T. (2016) · theses.fr (ABES) · doi:10.70675/11bcd9acz165fz4338zb013z5a469c5aed72
Calvel, L. Y. (2014) · theses.fr (ABES) · doi:10.70675/6989b45ez5195z46e1z9f69zb130b767fabb
“…d’un antidépresseur fluoxétine Nous vérifions la réversibilité pharmacologique d’un phénotype dépressif par l’administration subchronique d’un antidépresseur type inhibiteur de la recapture en sérotonine : la fluoxetine (Dulawa 2004, Holmes 2008, Inhe et al., 2012, Cunha et al., 2013).”
Rôle de la néoglucogenèse intestinale dans les comportements émotionnels
Sinet, F. (2016) · theses.fr (ABES) · doi:10.70675/4bdbc38bzee8ez43d0z8728z0933709d9d69 · Cited by 1
Effects of increasing adult hippocampal neurogenesis in a naturalistic mouse model of depression
Čulig, L. (2017) · theses.fr (ABES) · doi:10.70675/a5e6de1bze5ffz451dz8a32z93a14b44f2f2
Potential muscular doping effects of anti-depressants
Tutakhail, A. (2019) · theses.fr (ABES) · doi:10.70675/f3cbba2dza035z4ef0zaebbz68fe16432b48
Neuropathic pain and depression : molecular alterations in the anterior cingulate cortex
Humo, M. (2019) · theses.fr (ABES) · doi:10.70675/e72f9364z66cbz45c4z8b42zb7f3564cd3d0
Samante, F. I., Galangue, C. G., Avelino, D. C., Beltran, A. J., Rapada, M., Pabia, E. G., Bustamante, N. A., Botanas, C. J., Samante, F. L., Bormate, K. J., et al. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00851-9
Circadian system in diurnal and nocturnal rodents : role of the arousal system
Caputo, R. (2022) · theses.fr (ABES) · doi:10.70675/6b1f5b82zb4a3z406ezbcc6z8c32df00ee52
La kétamine, un antidépresseur d'action rapide et antagoniste du récepteur NMDA du glutamate
Nguyen, T. M. L. (2023) · theses.fr (ABES) · doi:10.70675/0ba94412ze24bz4514z9262z9ace4cb240c9
Fatima, F. K., Afifa, A. T., Ali, W., Ali, A. O., & Sahar, S. H. A. (2026) · Research Square · doi:10.21203/rs.3.rs-9779391/v1
Optimization and evaluation of a chronic variable stress model of depressive-like behaviors in mice
Du, L., Guo, Y., Fang, S., Zuo, W., Xie, X., Zeng, Y., Wang, Q., Kou, J., Hou, W., & Wang, M. (2026) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2026.110824
POTENTIAL MECHANISMS UNDERLYING FLUOXETINE ADVERSE EVENTS
Oskina, N., Mikheeva, R., & Koryukov, M. (2024) · Problems of Biological Medical and Pharmaceutical Chemistry · doi:10.29296/25877313-2026-07-07
Yamasaki, T., Onaka, Y., Yamaguchi, T., & Yoneyama, M. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150520
The Novelty-Suppressed Feeding Test in Mice
Reisinger, S. N., Gubert, C., Liao, H., Renoir, T., & Hannan, A. J. (2026) · Neuromethods · doi:10.1007/978-1-0716-5599-3_3
Pramanik, A., Sarkar, D., Mondal, P., Saha, J., Mahanti, K., Mahato, M., Majumdar, S., Pramanik, A., & Bhattacharyya, S. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70722
Behavioral and immunolgical effects of repeated social defeat
Kinsey, S. G. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Hanke, M. L. (2010) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Metadata
- Authors
- Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R.
- Affiliations
- Columbia University (US)
- Venue
- Neuropsychopharmacology
- Published
- 2004-04-07
- Volume
- 29
- Issue
- 7
- Pages
- 1321-1330
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1987972424
- Cited by
- 671
- References
- 50
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 27 · 2023: 28 · 2022: 32 · 2021: 32 · 2020: 31 · 2019: 51 · 2018: 31 · 2017: 42 · 2016: 34 · 2015: 42 · 2014: 41 · 2013: 44 · 2012: 28
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression (MH068542-1)
- National Institutes of Health (5r01da009862-08, 5f32mh065791-02)
- National Institute of Mental Health (F32-MH65791-01A1, P50MH050733, P50-MH50733, R01 MH068542-1, R01MH068542)
- National Institute on Drug Abuse (R01 DA09862)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- fluoxetine, chronic antidepressant treatment, anxiety, depression, selective serotonin reuptake inhibitors, inbred mouse strains, BALB/c mice, forced swim test, novelty-induced hypophagia, locomotor activity, antidepressant sensitivity
- MeSH terms
- Analysis of Variance, Animals, Anxiety, Behavior, Animal, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Administration Schedule, Exploratory Behavior, Fluoxetine, Immobilization, Male, Mice, Inbred Strains, Motor Activity, Reaction Time, Species Specificity, Swimming, Time Factors, Selective Serotonin Reuptake Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.